Ratings by Citizens (Silvan Turkcan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | Prime Medicine | PRME | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/3/2026 | Relay Therapeutics | RLAY | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/3/2026 | Nuvation Bio Inc | NUVB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 3/3/2026 | Intellia Therapeutics | NTLA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/25/2026 | Benitec BioPharma | BNTC | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/24/2026 | MacroGenics | MGNX | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 2/11/2026 | Exelixis | EXEL | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/10/2026 | Solid Biosciences | SLDB | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 2/6/2026 | Ideaya Biosciences | IDYA | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/9/2026 | Jasper Therapeutics | JSPR | Maintain | Market Outperform (Market Outperform) |
|
Details | ||
| 1/5/2026 | Engene Holdings Inc. | ENGN | Maintain | Market Outperform (Market Outperform) |
|
Details |
